CUC Inc. (JP:9158)
:9158
Top Page
CUC Inc.
(9158)
Select Model
Select Model
Rating:68Neutral
Price Target:
¥1,139.00
▲(34.32% Upside)
Action:ReiteratedDate:02/04/26
The score is driven primarily by strong financial performance in growth and margins, offset by negative free cash flow and only moderate cash conversion. Technically, the stock shows mixed signals with weak longer-term trend and negative MACD despite neutral RSI and some near-term support. Valuation appears reasonable with a mid-teens P/E, but no dividend data is available to add support.
Positive Factors
Revenue Growth
Sustained ~42.5% year-over-year revenue expansion indicates strong demand and market penetration in its care facilities business. This scale growth supports investment in capacity, creates pricing leverage, and underpins multiyear top-line visibility that can fund margin improvement and strategic initiatives.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow (-3.0B) constrains internal funding for capital expenditures, debt paydown, and strategic investments. Over months this reduces financial flexibility, may force reliance on external financing, and raises execution risk if operating improvements fail to translate into positive cash conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained ~42.5% year-over-year revenue expansion indicates strong demand and market penetration in its care facilities business. This scale growth supports investment in capacity, creates pricing leverage, and underpins multiyear top-line visibility that can fund margin improvement and strategic initiatives.
Read all positive factors
CUC Inc. (9158) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥30.63B
Dividend YieldN/A
Average Volume (3M)143.75K
Price to Earnings (P/E)7.6
Beta (1Y)0.90
Revenue Growth31.65%
EPS Growth-51.36%
CountryJP
Employees3,743
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)27.98
Shares Outstanding29,990,400
10 Day Avg. Volume142,970
30 Day Avg. Volume143,746
Financial Highlights & Ratios
PEG Ratio0.94
Price to Book (P/B)1.36
Price to Sales (P/S)0.85
P/FCF Ratio-13.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,050.00Price Target Upside23.82% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)91.44
Revenue Forecast (FY)¥61.83B
CUC Inc. Business Overview & Revenue Model
Company Description
CUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consu...
CUC Inc. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
75
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.44B | 47.04B | 33.02B | 35.21B | 35.31B | 16.61B |
| Gross Profit | 21.32B | 19.90B | 14.12B | 12.55B | 13.18B | 6.75B |
| EBITDA | 7.87B | 8.08B | 5.52B | 4.93B | 6.53B | 2.64B |
| Net Income | 2.37B | 3.13B | 2.60B | 2.42B | 2.71B | 1.10B |
Balance Sheet | ||||||
| Total Assets | 86.17B | 85.17B | 62.84B | 39.75B | 34.53B | 28.45B |
| Cash, Cash Equivalents and Short-Term Investments | 7.04B | 7.53B | 8.26B | 4.12B | 4.36B | 3.62B |
| Total Debt | 45.36B | 43.54B | 26.72B | 21.45B | 14.90B | 18.77B |
| Total Liabilities | 56.07B | 54.88B | 34.83B | 27.83B | 24.85B | 23.11B |
| Stockholders Equity | 29.54B | 29.68B | 27.32B | 11.70B | 9.46B | 4.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.04B | -703.00M | -3.10B | 5.79B | 1.73B |
| Operating Cash Flow | 0.00 | 2.50B | 4.16B | 2.36B | 6.62B | 2.12B |
| Investing Cash Flow | 0.00 | 4.45B | -14.75B | -6.68B | -1.47B | -2.42B |
| Financing Cash Flow | 0.00 | -7.60B | 14.37B | 3.97B | -4.43B | -591.00M |
CUC Inc. Technical Analysis
Positive
848.00
Price Trends
907.66
Positive
908.62
Positive
1025.85
Positive
Market Momentum
28.71
Negative
71.50
Negative
93.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9158, the sentiment is Positive. The current price of 848 is below the 20-day moving average (MA) of 901.70, below the 50-day MA of 907.66, and below the 200-day MA of 1025.85, indicating a bullish trend. The MACD of 28.71 indicates Negative momentum. The RSI at 71.50 is Negative, neither overbought nor oversold. The STOCH value of 93.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9158.
CUC Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥45.39B | 11.61 | ― | 2.63% | 0.30% | -31.28% | |
71 Outperform | ¥5.78B | 12.28 | ― | ― | 16.12% | 107.25% | |
68 Neutral | ¥30.63B | 7.58 | ― | ― | 31.65% | -51.36% | |
57 Neutral | ¥2.49B | 2.69 | ― | 4.76% | 1.84% | 92.34% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥5.88B | 23.20 | ― | 4.07% | 6.08% | 38.00% | |
45 Neutral | ¥6.66B | 33.86 | ― | 1.41% | 18.03% | -11.68% |
* Healthcare Sector Average
JP:9158
CUC Inc.
1,045.00
-117.00
-10.07%
JP:2373
Care Twentyone Corporation
437.00
75.63
20.93%
JP:2435
Cedar. Co.,Ltd
222.00
39.60
21.71%
JP:6062
Charm Care Corporation
1,392.00
282.83
25.50%
JP:7061
Japan Hospice Holdings Inc.
790.00
-524.18
-39.89%
JP:7091
Living Platform Ltd.
1,290.00
324.07
33.55%
CUC Inc. Corporate Events
CUC to Sell Medical-Focused Tokyo Real Estate, Booking ¥1.4 Billion Gain
Mar 19, 2026
CUC Inc. has approved the sale of trust beneficiary rights in land located in Shinjuku, Tokyo, held by its real estate leasing subsidiary CUC Properties Inc., to Fuyo General Lease Co., Ltd. for ¥3.4 billion, realizing an estimated gain on sa...
CUC Inc. Grows Revenue but Profit and EPS Decline Sharply in Nine-Month Results
Feb 2, 2026
For the nine months ended December 31, 2025, CUC Inc. reported revenue of ¥40.17 billion, up 16.2% year-on-year, but saw a sharp decline in profitability, with operating profit down 30.5% to ¥3.18 billion and net income attributable to s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.